When Breath Becomes a Galaxy: A New Era of Smart Respiratory Care Begins
A revolution in medical experience has begun—where breath transforms into stardust trails, and cutting-edge innovation meets aesthetic elegance. Yesterday, the AeroIns+ StarSmart Nebulizer by Feellife was honored with the 2025 Red Dot Award: Product Design, thanks to its groundbreaking AiMesh® technology and Air 360® respiratory sensing system.
This marks Feellife’s third major international design recognition, following the French Design Awards and the International Design Awards (IDA), solidifying China’s presence in the global innovation arena and redefining the future of respiratory health management.
Red Dot Award: The Ultimate Trial by Design
The Red Dot Award, often dubbed the "Oscars of industrial design," is known for its rigorous evaluation based on innovation, functionality, aesthetic quality, and human-centered design. In 2025, AeroIns+ stood out among over 10,000 entries from more than 60 countries—becoming the first medical nebulizer to receive this prestigious accolade this year.
Core Technologies: Redefining Efficiency and Empathy in Nebulization
1. AiMesh® – Intelligent Mesh Nebulization Technology
Feellife’s proprietary bio-elastic mesh features a bionic honeycomb structure that’s highly durable and rupture-resistant under vibration. It ensures smooth atomization, reduces liquid waste, prevents clogging, and guards against dry burning—delivering every drop with precision and safety.
2. Air 360® Respiratory Sensing – Teaching Machines to Breathe
Equipped with advanced breathing sensors, AeroIns+ detects real-time breathing patterns and automatically adjusts nebulization output, creating a truly personalized treatment experience.
3. StarSmart Interface – Turning Data Into Art
The world's first interactive nebulizer screen inspired by dynamic starlight. As you inhale and exhale, your respiratory data transforms into mesmerizing particle trails—turning treatment into an interstellar journey.
4. Bluetooth 5.0 + iBreathe® App Integration
Instant connection to the iBreathe® app allows users to generate detailed 3D respiratory health maps. Dr. Laura from Bologna Hospital, Italy, calls it "a flawless fusion of medical precision and digital artistry."
From Europe's Hospitals to Global Homes
With a mission to pioneer the “third pathway for drug delivery,” Feellife has already secured over 250 global patents and certifications. Its AiMesh®-powered devices, including the clinical-grade AirICU, are now used in ICUs across more than 40 countries, marking a significant milestone in respiratory therapeutics.
Behind the Breakthrough: 2000 Hours Under the Stars
To perfect the cosmic interface, Feellife’s R&D team camped in high-altitude regions to capture authentic star trail data. Every detail—from the tactile feel of silicone buttons to the visual dynamics of the interface—was fine-tuned through over 1,000 blind user tests, all in pursuit of harmony between design and empathy.
AeroIns+ is not just a medical device—it's a vision of the future, where breath, technology, and beauty converge.